Drug-Eluting Stent Market Size, Share, & COVID-19 Impact Analysis | Global | 2023-2029 | MedCore
- Year: 2023
- Scope: 10 Years
- Region: Global
- Pages: 24
- Published Date: 02/09/2023
- Type: MedCore
Overall, the global drug-eluting stent market was valued at $105.6 million in 2022. This is expected to increase over the forecast period at a CAGR of 1.8% to reach $119.6 million.
The full report suite on the global market for drug-eluting stents focuses on drug-eluting stents only and does not include the market’s extended set.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL DRUG-ELUTING STENT MARKET INSIGHTS
The most important driver for this market is the lack of competition. Intersect ENT is the only competitor in the market. The monopoly the company has makes it possible to keep the selling price at higher levels, which will drive up the market.
GLOBAL DRUG-ELUTING STENT MARKET SHARE INSIGHTS
The Global drug-eluting stent market was controlled by Intersect ENT.
Intersect ENT held a monopoly in the drug-eluting stent market with its Propel®family. The Propel® family of products is indicated to be used in conjunction with ethmoid sinus surgery. The different shapes and sizes of the three options have been designed to accommodate different sinus anatomies. The company also offers Sinuva® Sinus Implant.Sinuva® is used for the treatment of nasal polyps in patients who have undergone a previous ethmoid sinus surgery. Both Propel® and Sinuva® implants elute the corticosteroid mometasone furoate.
MARKET SEGMENTATION SUMMARY
- ENT Drug-Eluting Stent Market – MedCore
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast Period | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
| Drug-Eluting Stent Market |
| 12.1 Introduction |
| 12.2 Market Analysis and Forecast |
| 12.3 Drivers and Limiters |
| 12.3.1 Market Drivers |
| 12.3.2 Market Limiters |
| 12.4 Competitive Market Share Analysis |
Companies Included:
| Intersect ENT |
List of Charts
| Chart 12‑1: Drug-Eluting Stent Market, U.S., 2019 – 2029 |
List of Figures
| Figure 12‑1: Drug-Eluting Stent Market, U.S., 2019 – 2029 |
| Figure 12‑2: Leading Competitors, Drug-Eluting Stent Market, U.S., 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Drug-Eluting Stent Market Size, Share, & COVID-19 Impact Analysis | Global | 2023-2029 | MedCore
$4,995 – $8,995
The full report suite on the global market for drug-eluting stents focuses on drug-eluting stents only and does not include the market’s extended set.
- 2023
- 10 Years
- Global
- 02/09/2023
- 24
- MedCore
Related Reports
